Pfizer – Page 13

UK Government Selects Pfizer Over GSK to Supply RSV Vaccine Doses

1 year ago talkbio0Tagged Government, Pfizer, pharmaceutical companies, Respiratory syncytial virus, SmithKline Beecham, UK, Vaccines

Pfizer, GSK, RSV vaccine, UK government, pharmaceutical companies, vaccine supply

Pfizer’s Continuous Cost-Cutting: A $4B Savings Drive Extended to 2027

2 years ago talkbio0Tagged cost-cutting, Drug Industry, Efficiency, Financial savings, Pfizer, profitability, restructuring

Pfizer, cost-cutting, savings drive, 2027, pharmaceutical industry, restructuring, efficiency, profitability.

Sen. Wyden Scrutinizes Pfizer’s Tax Rate Amidst Ongoing Investigation

2 years ago talkbio0Tagged Avoidance, Corporate, Drug Industry, Evaluation, financial transparency, Pfizer, Rating (action), Taxation, Wyden

Sen. Wyden, Pfizer, tax rate, investigation, corporate taxation, tax avoidance, pharmaceutical industry, financial transparency

AstraZeneca Ordered to Pay Pfizer Over $107 Million in Tagrisso Patent Infringement Case

2 years ago talkbio0Tagged AstraZeneca, infringement, jury, Legal patent, Malignant neoplasm of lung, Pfizer, Tagrisso, Tissue damage

AstraZeneca, Pfizer, Tagrisso, patent infringement, jury verdict, damages, lung cancer treatment

Moderna Secures Victory in EU Patent Dispute with Pfizer-BioNTech over COVID-19 Vaccine

2 years ago talkbio0Tagged BioNTech, COVID19 (disease), Drug Industry, EPO, EU, European (ethnic group), Intellectual Property, Legal patent, Moderna, mRNA technology, Pfizer, Vaccines

Moderna, Pfizer, BioNTech, EU, patent dispute, COVID-19 vaccine, mRNA technology, European Patent Office (EPO), intellectual property rights, pharmaceutical industry.

Pharmaceutical Giants Sanofi, Pfizer, and AstraZeneca Pump $1.87 Billion into French Operations

2 years ago talkbio0Tagged AstraZeneca, development aspects, Drug Industry, France, Investments, Manufacture, Pfizer, production, research, sanofi, Surgical aspects, Vaccines

Sanofi, Pfizer, AstraZeneca, France, investment, pharmaceutical industry, operations, vaccine production, research and development, manufacturing.

Pfizer Temporarily Suspends Dosing in Advanced Duchenne Muscular Dystrophy (DMD) Trial After Patient Fatality

2 years ago talkbio0Tagged Clinical Trials, concerns, DMD, dosing, Duchenne, Evaluation, halt, late-stage study, Muscular Dystrophy, Muscular Dystrophy, Duchenne, Pfizer, Safety, Suspensions, Transitory

Pfizer, Duchenne Muscular Dystrophy (DMD), clinical trial, dosing halt, patient death, late-stage study, temporary suspension, safety concerns, investigation.